Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Cardiff Oncology Inc..
Cardiff Oncology Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Cardiff Oncology Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Cardiff Oncology Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Cardiff Oncology Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Cardiff Oncology Inc. and all latest updates of the company are provided.
The 2025 version of Cardiff Oncology Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Cardiff Oncology Inc.- Key Facts
2.2 Cardiff Oncology Inc.- Geographic Locations
2.3 Cardiff Oncology Inc.- Subsidiaries and Affiliates
2.4 Cardiff Oncology Inc.- Business Divisions
2.5 Cardiff Oncology Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Cardiff Oncology Inc. Strategic Analysis Review
3.1 Cardiff Oncology Inc.- Key Strategies
3.2 Cardiff Oncology Inc.- Company Outlook Statement
3.3 Cardiff Oncology Inc.- SWOT Analysis
3.3.1 Cardiff Oncology Inc.- Key Strengths
3.3.2 Cardiff Oncology Inc.- Key Weaknesses
3.3.3 Cardiff Oncology Inc.- Potential Opportunities
3.3.4 Cardiff Oncology Inc.- Potential Threats
3.4 Cardiff Oncology Inc.- Key Competitors
4. Business Description of the Company
4.1 Cardiff Oncology Inc.- Business Overview
4.2 Cardiff Oncology Inc.- Operations by Segment
5 Products and Services Details
5.1 Cardiff Oncology Inc.- Key Products
5.2 Cardiff Oncology Inc.- Key Service Areas
5.3 Cardiff Oncology Inc.- Key Brands
6 Company Developments
6.1 Cardiff Oncology Inc.- Company History
6.2 Cardiff Oncology Inc.- Latest Developments
7 Financial Analysis
7.1 Cardiff Oncology Inc.- Income Statements
7.2 Cardiff Oncology Inc.- Balance Sheet
7.3 Cardiff Oncology Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Cardiff Oncology Inc.- Direct Competitors
8.2 Cardiff Oncology Inc.- Competitor Financial Ratios comparison
8.3 Cardiff Oncology Inc.- Competitor Stock Charts Comparison
8.4 Cardiff Oncology Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!